Suppr超能文献

葡萄糖诱导肾脏近端肾小管上皮细胞中转氨酶的下调导致糖尿病中硫胺素不足。

Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes.

机构信息

Warwick Medical School, Clinical Sciences Research Laboratories, University of Warwick, University Hospital, Coventry, United Kingdom.

出版信息

PLoS One. 2012;7(12):e53175. doi: 10.1371/journal.pone.0053175. Epub 2012 Dec 28.

Abstract

Increased renal clearance of thiamine (vitamin B(1)) occurs in experimental and clinical diabetes producing thiamine insufficiency mediated by impaired tubular re-uptake and linked to the development of diabetic nephropathy. We studied the mechanism of impaired renal re-uptake of thiamine in diabetes. Expression of thiamine transporter proteins THTR-1 and THTR-2 in normal human kidney sections examined by immunohistochemistry showed intense polarised staining of the apical, luminal membranes in proximal tubules for THTR-1 and THTR-2 of the cortex and uniform, diffuse staining throughout cells of the collecting duct for THTR-1 and THTR-2 of the medulla. Human primary proximal tubule epithelial cells were incubated with low and high glucose concentration, 5 and 26 mmol/l, respectively. In high glucose concentration there was decreased expression of THTR-1 and THTR-2 (transporter mRNA: -76% and -53% respectively, p<0.001; transporter protein -77% and -83% respectively, p<0.05), concomitant with decreased expression of transcription factor specificity protein-1. High glucose concentration also produced a 37% decrease in apical to basolateral transport of thiamine transport across cell monolayers. Intensification of glycemic control corrected increased fractional excretion of thiamine in experimental diabetes. We conclude that glucose-induced decreased expression of thiamine transporters in the tubular epithelium may mediate renal mishandling of thiamine in diabetes. This is a novel mechanism of thiamine insufficiency linked to diabetic nephropathy.

摘要

在实验性和临床糖尿病中,噻嗪(维生素 B(1))的肾清除率增加,这是由肾小管重吸收受损引起的噻嗪不足介导的,与糖尿病肾病的发展有关。我们研究了糖尿病中噻嗪肾重吸收受损的机制。免疫组织化学检查正常人肾脏切片中噻嗪转运蛋白 THTR-1 和 THTR-2 的表达,显示近端肾小管的顶端、腔膜上有强烈的极化染色,皮质的 THTR-1 和 THTR-2 以及髓质的 THTR-1 和 THTR-2 均为均匀、弥漫的染色。将人原代近端肾小管上皮细胞在低(5 mmol/l)和高(26 mmol/l)葡萄糖浓度下孵育。在高葡萄糖浓度下,THTR-1 和 THTR-2 的表达减少(转运体 mRNA:分别减少 76%和 53%,p<0.001;转运体蛋白:分别减少 77%和 83%,p<0.05),同时转录因子特异性蛋白-1 的表达减少。高葡萄糖浓度还使噻嗪穿过细胞单层的顶端到基底外侧转运减少 37%。强化血糖控制纠正了实验性糖尿病中噻嗪排泄分数的增加。我们得出结论,葡萄糖诱导的肾小管上皮中噻嗪转运体表达减少可能介导了糖尿病中噻嗪的肾脏处理不当。这是与糖尿病肾病相关的噻嗪不足的新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cda/3532206/df596b5cb17b/pone.0053175.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验